Skip to main content

Day: January 22, 2024

Chicory Market Size Worth USD 1391.4 Million in 2032 | Emergen Research

Increasing need for chicory as a coffee alternative, rising demand for chicory in the nutraceutical and pharmaceutical industries, and technological advancements in the extraction and processing of high-purity chicory extracts are key factors driving chicory market revenue growth. Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) — The global chicory market size was USD 739.6 million in 2022 and is expected to register a rapid revenue CAGR of 6.5% during the forecast period. Increasing need for chicory as a coffee alternative, rising demand for chicory in the nutraceutical and pharmaceutical industries, and technological advancements in the extraction and processing of high-purity chicory extracts are key factors driving market revenue growth. The rising number of diabetes patients is another key factor driving revenue growth of the market....

Continue reading

Music Licensing, Inc. (OTC: SONG) Achieves Milestone Royalty Payments, Unveils Aggressive Expansion Plan with $5,000,000 USD Music Intellectual Property Acquisition

Naples, Florida, Jan. 22, 2024 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG) proudly announces the reception of its inaugural royalty payments totaling $6,345.97 USD from globally renowned artists, including Elton John, Miley Cyrus, Lil Wayne, Lil Nas X, XXXTENTACION, and Halsey. This significant accomplishment marks a pivotal moment in the company’s trajectory, highlighting success in innovation and revenue diversification. Building on this success, Music Licensing, Inc. reveals its strategic plan to scale up through the acquisition of an additional $5,000,000 USD worth of Music intellectual property royalty stakes. This aggressive expansion aims to further solidify the company’s position in the industry and contribute to its ongoing success. With the anticipation of acquiring deals with similar metrics, Music...

Continue reading

BUREAU VERITAS – Number of shares and voting rights as of December 31, 2023

REGULATED INFORMATION Neuilly-sur-Seine, France – January 22, 2024 Information on number of shares and voting rights as stipulated by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau VeritasDate Number of shares(1) Number of voting rights31/12/2023 453,871,520 Theoretical number of voting rights: 624,110,946 Number of exercisable voting rights: 623,870,261(1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2023.                Bureau Veritas Head Office Tel: + 33 (0)1 55 24 70 00Société Anonyme Immeuble Newtime Fax: + 33 (0)1 55 24 70 01(Limited liability corporation) 40/52 boulevard du Parc www.bureauveritas.comShare capital of EUR 54,464,582.40 92200 Neuilly-sur-Seine  RCS Nanterre 775 690 621 France  ...

Continue reading

Disclosure of transactions in own shares from January 15th to January 19th, 2024

         Nanterre, January 22nd, 2024                      Disclosure of transactions in own shares from January 15th to January 19th, 2024 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 13, 2023 to trade in its shares and in accordance with the regulations relating to share buybacks, VINCISA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out From January 15th to January 19th, 2024: I – Aggregate presentation by day and by marketIssuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)           VINCI 15/01/2024 FR0000125486 1 069 116,04990 XPARVINCI 16/01/2024 FR0000125486 1 632...

Continue reading

Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer

Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of James Wentworth, PhD, MBA, as Chief Business Officer (CBO) and member of the executive management team, effective immediately. Dr. Wentworth will be responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategies.  Alessandro Riva, MD, Chairman and CEO of Transgene, comments: “I am very pleased to welcome James, at a pivotal time for Transgene as we seek to develop novel cancer immunotherapies including an individualized neoantigen cancer vaccine. Our business development strategy will be crucial to achieving our goals, and James’ significant experience...

Continue reading

Update share buyback program (22 January 2024)

Update share buyback program (22 January 2024) Regulated information 22 January 2024 – 17.45 CET On 22 September 2023, Kinepolis Group announced the launch of its Share buyback program to cover share options. This program started on 25 September 2023 and ends on 24 March 2024 at the latest. Under this program, Kinepolis Group may buy back, through the appointed independent intermediary, up to 151,000 shares on Euronext Brussels for a total maximum amount of € 8 million. During the period from 15 January 2024 to 19 January 2024, the following transactions were carried out on Euronext Brussels under this program:Date Number of shares Average price (EUR)1 Lowest price (EUR) Highest price(EUR) Total(EUR)15/01/2024 1,400 € 43.70 € 43.60 € 43.80 € 61,180.0016/01/2024 5,000 € 41.93 € 40.50 € 42.85 € 209,652.5017/01/2024 1,750 €...

Continue reading

Brunswick Starts Phase II Drilling at Mirage, Globex Royalty, Lithium Property

ROUYN-NORANDA, Jan. 22, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to report that Brunswick Exploration Inc. (BRW-TSXV, BRWXF-OTCQB) have started “A Phase II drilling campaign at the Mirage (Lac Escale) project, located in the Eeyou-Istchee James Bay region of Quebec. The winter drill program is targeting extensions of known pegmatite dykes (MR-1 to MR-6) and new prospective outcrops that have yet to be drill-tested.” “The planned drill holes are distributed over the 2.8 kilometer known strike length to test the entire spodumene-bearing pegmatite dyke swarm”. Previous drilling intersected...

Continue reading

New composition of Ageas’s Executive Committee

New composition of Ageas’s Executive Committee Today Ageas announces upcoming organisational changes within its Executive Committee with the objective to align its governance model to the strategic ambitions of the Group. Ageas is reinforcing the Group’s current Executive Committee by including all its 4 business segments (Europe, Asia, Belgium, and Reinsurance), complemented by a newly created function of Managing Director Business Development. The latter function will be responsible for the development and implementation of the Group’s strategy, and for the further evolution of its footprint. The changes are being implemented to:better reflect the current business profile taking into account the evolving importance and size of the Group’s different activities. simplify and improve the integration of corporate and business decision...

Continue reading

Reverse share split registered

Oslo, Norway, 22 January 2024 Interoil Exploration and Production ASA (the “Company”) refers to the resolution made by the Company’s Extraordinary General Meeting on 18 December 2023 to do a reverse share split (share consolidation) of the Company’s shares in the ratio of 10:1 to meet Oslo Børs’ requirements of a minimum share value of NOK 1 per share, and the announcement of key information relating to the share consolidation published on 19 January 2024. The reverse share split has now been registered with the Norwegian Register of Business Enterprises. Following such registration, the Company’s registered share capital is NOK 100,672,140, divided into 20,134,428 shares, each with a par value of NOK 5.00. This information is subject to the disclosure requirements pursuant to Oslo Rule Book II for companies...

Continue reading

Clinical Nutrition Market Set to Soar Past USD 22.9 Billion by 2030

The global Clinical Nutrition market size is expected to reach USD 22.9 billion by 2030 and exhibit a CAGR of 5% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing prevalence of chronic diseases and disorders, growing geriatric population, rising awareness about the importance of proper nutrition in healthcare, advancements in medical research and technology, expanding product portfolios by key players in the market, government initiatives and policies promoting clinical nutrition, are fueling the Market’s growth. Westford, USA, Jan. 22, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Clinical Nutrition Market, personalized nutrition and nutrigenomics, plant-based and vegan clinical nutrition products, clean label and natural ingredients,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.